D&C biotechnology Inc.

Ajou University Medical Center and D&C Biotechnology Sign Joint Research Agreement

  • 2023.04.04

D&C Biotechnology Inc. (CEO Park Sung-soo) announced on the 31st that it has signed a memorandum of understanding (MOU) for joint research in the medical device field with Ajou University Medical Center (Director Park Hae-shim).

 

The agreement aims to lead innovation in medical devices through academic exchange and joint research while fostering mutual growth through collaborative achievements.

 

Under this agreement, the two organizations will collaborate in areas requiring mutual cooperation, including:

  • Research and development of innovative medical devices
  • Technology transfer and commercialization based on joint research outcomes
  • Exchange of R&D personnel and shared utilization of research infrastructure
  • Other initiatives to enhance mutual goodwill and share information.

 

At the signing ceremony, Director Kim Cheol-ho of Ajou University’s Advanced Medical Research Institute stated, “This partnership will yield excellent outcomes in innovative medical device development by leveraging the data and technologies of both organizations. It will also enable Ajou University Medical Center to further establish itself as a research-oriented hospital.”

 

CEO Park Sung-soo of D&C Biotechnology remarked, “By utilizing Ajou University Medical Center’s outstanding research resources as a research-oriented hospital, we will strengthen our company’s R&D capabilities and contribute to regional medical advancement through the development of innovative medical devices.”

© 2025 D&C Biotechnology Inc. All Rights Reserved.

위로 스크롤
Close

Data Privacy Notice (Privacy Policy)

Article 1 (Consent to Collection of Personal Information) D&C Biotechnology has set up a procedure whereby users can click the “Agree” or “Cancel” button for the content of D&C Biotechnology’s Privacy Policy or Terms of Use. By clicking the “Agree” button, you are deemed to have consented to the collection of personal information.

 

Article 2 (Personal Information Collection Items) The personal information items processed for consultation through online inquiries are as follows. Collection items: Name, Email, Phone number

 

Article 3 (Purpose of Use of Personal Information) D&C Biotechnology does not disclose users’ personal information without prior consent and collects personal information for smooth customer consultation and provision of various services as follows. All information will not be used for purposes other than those stated above, and prior consent will be obtained if the scope of information collected, purpose of use, or usage changes. Company name, name: Confirmation of identity for product consultation Email, Phone number: Delivery of product consultation and event-related notifications, provision of new service and new product information (DM, SMS, email, etc.) Users can refuse consent to the collection/use of personal information. However, if you refuse consent, online consultation is not possible and you may be restricted in using the service and receiving benefits.

 

Article 4 (Retention and Use Period of Personal Information) In principle, after the purpose of collecting and using personal information is achieved, the information is destroyed without delay. However, if there is a need for preservation in accordance with the provisions of related laws such as the Commercial Law, the Consumer Protection Act in E-commerce, etc., the company keeps the information for a certain period specified in related laws. In this case, the company uses the information stored only for the purpose of its preservation, and the preservation period is as follows. Record of contract or subscription withdrawal: 5 years (Consumer Protection Act in E-commerce, etc.) Record of consumer complaints or dispute resolution: 3 years (Consumer Protection Act in E-commerce, etc.) Record of collection/processing and use of credit information: 3 years (Act on the Use and Protection of Credit Information)

 

The company securely processes valuable user personal information and destroys personal information in the following ways to prevent leaks. Personal information printed on paper is destroyed by shredding or incineration. Personal information stored in electronic file format is deleted using a technical method that cannot reproduce the record

Close

Unauthorised Email Collection is Prohibited

[Unauthorised Email Collection is Prohibited]

 

The unauthorized collection of email addresses posted on this website, through email collection programs or any other technical devices, is strictly prohibited. This includes collecting email addresses without the prior consent of the website operator or administrator. Such unauthorized collection of email addresses is illegal. Violators will be subject to criminal punishment under

 

Article 50-2 of the Act on Promotion of Information and Communications Network Utilization and Information Protection.

 

Article 50-2 of the Act on Promotion of Information and Communications Network Utilization and Information Protection (Prohibition of Unauthorized Collection of E-mail Addresses)

 

  1. No one shall use a program or any other technical device to automatically collect email addresses from the internet website, without the prior consent of the website operator or administrator.
  2. No one shall sell or distribute email addresses collected in violation of paragraph 1.
  3. No one shall knowingly use email addresses, collected, sold or distributed in violation of paragraphs 1 and 2, for the purpose of transmitting information.